Acceptability of Human Papillomavirus Self-sampling in Women Living With HIV

Women living with HIV are unsufficiently screened for cervix cancer although they have a higher risk of developping it, resulting in many obstacles. Offering a new screening technique, more accessible and which doesn't require gynecologic examination, could help improving this coverage rate. Human Papillomavirus (HPV) screening have a higher-performance for cervix cancer than smear test. Self-collected vaginal swabs are as efficient as vaginal swabs performed by clinicians. They are also shown as acceptable among general population but only one study in South Africa has been performed on women living with HIV. In addition, recent studies on urine self-sampling for high risk HPV (HR-HPV) screening report satisfactory performance. The main hypothesis is that self-collected vaginal swabs and urine self-sampling are also acceptable among women living with HIV in the CoreVIH Ile de France Nord (CoreVIH) cohort.

Sex

Female

Minimum age

30 Years

Inclusion criteria :

* HIV-positive women over or equal to 30 years old
* HIV-positive patient who has already consulted at least once at the CoreVIH Ile de France Nord

Exclusion criteria :

* Refusal to sign a consent form
* Personal history of cervical cancer, conization, suspicious smears undergoing exploration or known high oncogen risk HPV
* Ongoing menstruation
* Physical impossibility to carry out self-sampling (e.g. motor disability, significant visual disturbances)
* Ongoing gynecological infection
* Patient not affiliated to a social security scheme or without AME
* Protected adult patient (under guardianship, curatorship)
* Pregnant or breastfeeding woman